These drugs are not without risk. The Drug Controller General of India continues to monitor the situation closely as the market expands following generic entry
What we like about the venue: Atmosphere: Modern, redefining and friendly
Effect size is not the same as clinical usefulness
Differences in trial duration (6880 wk), populations, dose pooling, DXA timing, estimands, and body-composition calculation methods preclude direct ranking.
For example, David Kessler, MD, who used to run the FDA, wrote an article about GLP-1 drugs for Harvard Magazine
Targeting therapeutics against glutathione depletion in diabetes and its complications